Your session is about to expire
← Back to Search
SPACE Parental-Guidance for Failure to Launch (SPACE-FTL Trial)
N/A
Waitlist Available
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up once before and once after the 13 weeks of therapy
Awards & highlights
SPACE-FTL Trial Summary
This trial will study whether the SPACE program can help parents of adult children who are highly dependent. Researchers will also look at how well participants accept and follow the SPACE program.
Eligible Conditions
- Anxiety Disorders
- Failure to Launch
- Hikikomori
SPACE-FTL Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ once before and once after the 13 weeks of therapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once before and once after the 13 weeks of therapy
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in FTL status
Change in FTL symptoms
Change in clinical severity
Secondary outcome measures
Mental disorders
Change in family accommodation
SPACE-FTL Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment group (active)Experimental Treatment1 Intervention
Individuals in this group will start treatment after the initial assessment, without a delay.
Group II: Wait-list control groupActive Control1 Intervention
Individuals in this group will start treatment after the initial assessment, with a delay of thirteen weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SPACE parental-guidance
2020
N/A
~40
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,737,628 Total Patients Enrolled
18 Trials studying Anxiety Disorders
3,636 Patients Enrolled for Anxiety Disorders
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You still live with your parents.Unemployed for more than 10 hours per week, not actively engaged in educational programs.The individual who has FTL has suffered a major injury or disease and is unable to work or study as a result.People with a condition called FTL will be identified as:The person with FTL (Frontotemporal Lobar Degeneration) is experiencing severe suicidal thoughts and needs more intensive treatment.I agree to take part in this study and consent to all study procedures.You have been diagnosed with a serious mental disorder such as bipolar disorder, schizophrenia, autism, or intellectual disability according to your parents.This condition has been met for at least six months.You have a problem with using drugs or engaging in addictive behaviors.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment group (active)
- Group 2: Wait-list control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Connecticut
How old are they?
18 - 65
What site did they apply to?
Yale University Child Study Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger